Hims & Hers Health (HIMS) EBITDA Margin (QoQ) (2020 - 2026)
Hims & Hers Health (HIMS) EBITDA Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.49 Bn | 43.53 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.68 Bn | 40.02 Bn | 2.15 Bn |
| 3 | Zoetis | 32.32 Bn | 30.65 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.62 Bn | 22.82 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.98 Bn | 19.32 Bn | 683.80 Mn |
| 6 | Viatris | 18.99 Bn | 18.10 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Hims & Hers Health | 7.80 Bn | 6.96 Bn | 480.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.00 |
| Mar 31, 2026 | -1,437.00 |
| Dec 31, 2025 | -48.00 |
| Sep 30, 2025 | -293.00 |
| Jun 30, 2025 | -498.00 |
| Mar 31, 2025 | 601.00 |
| Dec 31, 2024 | -171.00 |
| Sep 30, 2024 | 208.00 |
| Jun 30, 2024 | -7.00 |
| Mar 31, 2024 | 372.00 |
| Dec 31, 2023 | 361.00 |
| Sep 30, 2023 | 67.00 |
| Jun 30, 2023 | 146.00 |
| Mar 31, 2023 | 104.00 |
| Dec 31, 2022 | 686.00 |
| Sep 30, 2022 | 398.00 |
| Jun 30, 2022 | -108.00 |
| Mar 31, 2022 | 876.00 |
| Dec 31, 2021 | 1,183.00 |
| Sep 30, 2021 | -861.00 |